Millions who undergo fat injections may experience severe, long-lasting consequences - here's immediate action to minimize risks.
In a recent warning, top pharmacist Deborah Grayson has urged patients and healthcare professionals to take the potential for severe and permanent digestive issues seriously when using weight loss jabs, also known as fat jabs. These jabs, such as Wegovy and Mounjaro, developed by Eli Lilly and Company, have been linked to reversing type 2 diabetes and various health benefits. However, Grayson has expressed concerns about the potential side effects, particularly gastroparesis, a condition where food passes through the stomach more slowly than it should.
Gastroparesis can bring about life-altering side effects such as persistent nausea, vomiting, bloating, or early satiety. Grayson advises patients experiencing these symptoms to speak to their GP immediately.
Manufacturers of weight loss jabs recommend that any patient experiencing side effects while taking the drugs report them to their healthcare provider and via the MHRA Yellow Card scheme. The NHS also advises sufferers of gastroparesis to see a GP when they feel symptoms, including feeling full quickly after eating, experiencing nausea or vomiting after eating, chronic stomach pain, constant heartburn for three weeks or more, and bloating for three weeks or more.
The risk of gastroparesis is higher in overweight/obese individuals, women, those with viral infections, and those with nervous system diseases like Parkinson's disease or multiple sclerosis. GLP-1 receptor agonists (GLP-1), the type of drugs used in fat jabs, work by mimicking a natural hormone in the body to reduce appetite, slow digestion, and increase insulin secretion.
Grayson has also expressed concern about treatments for gastroparesis, often proton pump inhibitors, which could cause further complications. She predicts an increase in people experiencing both persistent gastroparesis and reliance on proton pump inhibitors due to higher doses of GLP-1 medications.
Long-term use of proton pump inhibitors has been linked to conditions like dementia. Grayson advises doctors to monitor symptoms closely and consider alternatives for people with a history of gastrointestinal problems.
She recommends anyone starting weight loss jabs to be fully aware of the potential for severe and, in some cases, permanent digestive issues. The use of these jabs, while offering potential health benefits, should be approached with caution and careful consideration of the potential risks.
Read also:
- Hospital's Enhancement of Outpatient Services Alleviates Emergency Department Strain
- Increased Chikungunya infections in UK travelers prompt mosquito bite caution
- Kazakhstan's Deputy Prime Minister holds discussions on the prevailing circumstances in Almaty
- In the state, Kaiser Permanente boasts the top-ranked health insurance program
